1.
Koliada O, Myroshnychenko M, Vdovichenko N, Krestetska S. Marker of intrathecal immune activation for the evaluation of the IFN-β efficacy in relapsing-remitting multiple sclerosis. AMI [Internet]. 2021Dec.9 [cited 2022Jul.6];(4):27-31. Available from: http://journals.uran.ua/ami/article/view/243398